IOL Chemicals and Pharmaceuticals Shareholding Pattern
- Market cap
- ₹5,996 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹147.07 – ₹275.76
As of Jun 2026, promoters held 48.50% of IOL Chemicals and Pharmaceuticals, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
IOL Chemicals and Pharmaceuticals shareholding pattern — frequently asked questions
What is the promoter holding in IOL Chemicals and Pharmaceuticals?
Promoters held 48.50% of IOL Chemicals and Pharmaceuticals as of Jun 2026.
How much do FIIs hold in IOL Chemicals and Pharmaceuticals?
Foreign institutional investors held 18.40% of IOL Chemicals and Pharmaceuticals as of Jun 2026.
How much do domestic institutions hold in IOL Chemicals and Pharmaceuticals?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of IOL Chemicals and Pharmaceuticals as of Jun 2026; mutual funds alone held 8.50%.
Who owns IOL Chemicals and Pharmaceuticals?
As of Jun 2026, IOL Chemicals and Pharmaceuticals' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- IPCA Laboratories Limited shareholding pattern
- Ind-Swift Laboratories Limited shareholding pattern
- Jagsonpal Pharmaceuticals Limited shareholding pattern
- Indraprastha Medical Corporation Limited shareholding pattern
- JHS Svendgaard Laboratories Limited shareholding pattern
- Indo Us Biotech Limited shareholding pattern
Trade IOL Chemicals and Pharmaceuticals With ATS
Track IOLCP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.